000			02184 a2200601 4500
005			20250517140758.0
264		0	_c20170814
008			201708s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/annrheumdis-2016-210189 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaier, Christiane
245	0	0	_aInhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cJun 2017
300			_a1133-1141 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aBleomycin
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCollagen _xmetabolism
650	0	4	_aCyclic Nucleotide Phosphodiesterases, Type 4 _xmetabolism
650	0	4	_aCytokines _xgenetics
650	0	4	_aDNA Topoisomerases, Type I _ximmunology
650	0	4	_aDisease Models, Animal
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aFibrosis
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aGraft vs Host Disease _xcomplications
650	0	4	_aHumans
650	0	4	_aInterleukin-13 _xgenetics
650	0	4	_aInterleukin-6 _xgenetics
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aPhosphodiesterase 4 Inhibitors _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRolipram _xpharmacology
650	0	4	_aScleroderma, Systemic _xdrug therapy
650	0	4	_aSkin _xdrug effects
650	0	4	_aThalidomide _xanalogs & derivatives
650	0	4	_aTransforming Growth Factor beta1 _xgenetics
650	0	4	_aTransforming Growth Factor beta2 _xgenetics
700	1		_aRamming, Andreas
700	1		_aBergmann, Christina
700	1		_aWeinkam, Rita
700	1		_aKittan, Nicolai
700	1		_aSchett, Georg
700	1		_aDistler, Jörg H W
700	1		_aBeyer, Christian
773	0		_tAnnals of the rheumatic diseases _gvol. 76 _gno. 6 _gp. 1133-1141
856	4	0	_uhttps://doi.org/10.1136/annrheumdis-2016-210189 _zAvailable from publisher's website
999			_c26888675 _d26888675